Journal Mobile Options
Table of Contents
Vol. 2, No. 5, 2002
Issue release date: 2002
Pancreatology 2002;2:469–477

Epidemiology of Pancreatic Diseases in Lüneburg County

A Study in a Defined German Population

Lankisch P.G. · Assmus C. · Maisonneuve P. · Lowenfels A.B.
aDepartment of Internal Medicine, Municipal Clinic of Lüneburg, Germany; bEuropean Institute of Oncology, Milano, Italy; cNew York Medical College, Valhalla, N.Y., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background/Aims: Worldwide, the incidence of pancreatic cancer is very well known, that of acute pancreatitis and chronic pancreatitis not. Our study sought to determine the incidence of all three pancreatic diseases in a well-defined population in Germany. Methods: Records of all patients treated for acute (first attacks only) and chronic pancreatitis as well as pancreatic cancer from 1988 to 1995 and who resided in the county of Lüneburg were evaluated. Results: The crude incidence rates for acute pancreatitis, chronic pancreatitis and pancreatic cancer per 100,000 inhabitants/year were 19.7, 6.4, and 7.8. In acute and chronic pancreatitis the male gender dominated, whereas in pancreatic carcinoma the gender ratio was almost even. Peak incidence for acute pancreatitis was in the age group of 35–44 years, for chronic pancreatitis 45–54, and for pancreatic cancer 65–75. Etiology of acute pancreatitis was biliary in 40%, alcohol abuse in 32%, unknown in 20%, and other in 8% of the patients. In chronic pancreatitis alcohol abuse was the etiology in 72% and unknown (idiopathic) in 28%. Conclusion: For the first time, epidemiological data obtained in a well-defined German population are being published relating to all three pancreatic diseases: acute pancreatitis (incidence rate, etiology and severity), chronic pancreatitis (incidence rate and etiology), and pancreatic carcinoma (incidence rate). A peak incidence of chronic pancreatitis occurring in an age group 10 years older than the peak age group for acute pancreatitis suggests that chronic pancreatitis develops during this time-frame following first attacks of acute pancreatitis.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JHC: Acute pancreatitis: Value of CT in establishing prognosis. Radiology 1990;174:331–336.
  2. Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP: The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994;107:1481–1487.
  3. Bradley EL III: The necessity for a clinical classification of acute pancreatitis: The Atlanta system; in Bradley EL III (ed): Acute Pancreatitis: Diagnosis and Therapy. New York, Raven Press, 1994, pp 27–32.
  4. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC: Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69–81.
  5. Ranson JHC: Etiological and prognostic factors in human acute pancreatitis: A review. Am J Gastroenterol 1982;77:633–638.
  6. Blamey SL, Imrie CW, O’Neill J, Gilmour WH, Carter DC: Prognostic factors in acute pancreatitis. Gut 1984;25:1340–1346.
  7. Wilson C, Imrie CW: Deaths from acute pancreatitis: Why do we miss the diagnosis so frequently? Int J Pancreatol 1988;3:273–282.

    External Resources

  8. Lankisch PG, Schirren CA, Kunze E: Undetected fatal acute pancreatitis: Why is the disease so frequently overlooked? Am J Gastroenterol 1991;86:322–326.
  9. Lankisch MR, Imoto M, Layer P, DiMagno EP: The effect of small amounts of alcohol on the clinical course of chronic pancreatitis. Mayo Clin Proc 2001;76:242–251.

    External Resources

  10. Deviere J, Cremer M, Baize M, Love J, Sugai B, Vandermeeren A: Management of common bile duct stricture caused by chronic pancreatitis with metal mesh self expandable stents. Gut 1994;35:122–126.
  11. Corfield AP, Cooper MJ, Williamson RCN: Acute pancreatitis: A lethal disease of increasing incidence. Gut 1985;26:724–729.
  12. Appelros S, Borgström A: Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg 1999;86:465–470.
  13. Giggs JA, Bourke JB, Katschinski B: The epidemiology of primary acute pancreatitis in Greater Nottingham: 1969–1983. Soc Sci Med 1988;26:79–89.
  14. Trapnell JE, Duncan EHL: Patterns of incidence in acute pancreatitis. Br Med J 1975;ii:179–183.
  15. Toh SKC, Phillips S, Johnson CD: A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England. Gut 2000;46:239–243.
  16. Tran DD, Van Schilfgaarde R: Prevalence and mortality from acute pancreatitis in the Netherlands during 1971–1990 (abstract). Digestion 1994;55:342–343.
  17. Eland IA, Sturkenboom MJCM, Wilson JHP, Stricker BHC: Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol 2000;35:1110–1116.
  18. Thomson HJ: Acute pancreatitis in North and North-East Scotland. J R Coll Surg Edinb 1985;30:104–110.

    External Resources

  19. Thomson SR, Hendry WS, McFarlane GA, Davidson AI: Epidemiology and outcome of acute pancreatitis. Br J Surg 1987;74:398–401.
  20. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW: High early mortality rate from acute pancreatitis in Scotland, 1984–1995. Br J Surg 1999;86:1302–1305.
  21. Worning H: Acute interstitial (edematous) pancreatitis in Denmark; in Bradley EL III (ed): Acute Pancreatitis: Diagnosis and Therapy. New York, Raven Press, 1994, pp 265–269.
  22. Go VLW: Etiology and epidemiology of pancreatitis in the United States; in Bradley EL III (ed): Acute Pancreatitis: Diagnosis and Therapy. New York, Raven Press, 1994, pp 235–239.
  23. Halvorsen F-A, Ritland S: Acute pancreatitis in Buskerud County, Norway: Incidence and etiology. Scand J Gastroenterol 1996;31:411–414.
  24. Jaakkola M, Nordback I: Pancreatitis in Finland between 1970 and 1989. Gut 1993;34:1255–1260.
  25. Sparrow M, Brazeau R, Collins H, Morrison RA (eds): International Survey of Alcoholic Beverage Taxation and Control Policies, ed 7. Ottawa, Brewers Association of Canada, 1989.
  26. Durbec JP, Sarles H: Epidemiology of chronic pancreatitis: Alcohol and dietary habits; in Gyr KE, Singer MV, Sarles H (eds): Pancreatitis – Concepts and Classification. Amsterdam, Elsevier, 1984, pp 351–353.
  27. Marks IN, Girdwood AH, Bornman PC, Feretis C: The prevalence and etiology of pancreatitis in Cape Town; in Gyr KE, Singer MV, Sarles H (eds): Pancreatitis – Concepts and Classification. Amsterdam, Excerpta Medica, 1984, pp 345–350.
  28. Mott CB, Guarita DR, Machado MCC, Bettarello A: Epidemiology and etiology of chronic pancreatitis in Sao Paulo (Brasil): A prospective study of 200 cases; in Gyr KE, Singer MV, Sarles H (eds): Pancreatitis – Concepts and Classification. Amsterdam, Excerpta Medica, 1984, pp 355–358.
  29. Robles-Díaz G, Vargas F, Uscanga L, Fernández-del Castillo C: Chronic pancreatitis in Mexico City. Pancreas 1990;5:479–483.
  30. The Copenhagen Pancreatitis Study Group: Copenhagen Pancreatitis Study: An interim report from a prospective epidemiological multicentre study. Scand J Gastroenterol 1981;16:305–312.
  31. Riela A, Zinsmeister AR, Melton LJ, DiMagno EP: Trends in the incidence and clinical characteristics of chronic pancreatitis (abstract). Pancreas 1990;5:727.
  32. Johnson CD, Hosking S: National statistics for diet, alcohol consumption, and chronic pancreatitis in England and Wales, 1960–88. Gut 1991;32:1401–1405.
  33. Angelini G, Pederzoli P, Caliari S, Fratton S, Brocco G, Marzoli G, Bovo P, Cavallini G, Scuro LA: Long-term outcome of acute necrohemorrhagic pancreatitis: A 4-year follow-up. Digestion 1984;30:131–137.
  34. Seidensticker F, Otto J, Lankisch PG: Recovery of the pancreas after acute pancreatitis is not necessarily complete. Int J Pancreatol 1995;17:225–229.
  35. Lambiase L, Forsmark CE, Albert C, Toskes PP: Secretin test diagnoses chronic pancreatitis earlier than ERCP (abstract). Gastroenterology 1993;104:A315.
  36. Lankisch PG, Seidensticker F, Otto J, Lübbers H, Mahlke R, Stöckmann F, Fölsch UR, Creutzfeldt W: Secretin-pancreozymin test (SPT) and endoscopic retrograde cholangiopancreatography (ERCP): Both are necessary for diagnosing or excluding chronic pancreatitis. Pancreas 1996;12:149–152.
  37. Lankisch PG, Andrén-Sandberg Å: Standards for the diagnosis of chronic pancreatitis and for the evaluation of treatment. Int J Pancreatol 1993;14:205–212.
  38. Worning H: Incidence and prevalence of chronic pancreatitis; in Beger HG, Büchler M, Ditschuneit H, Malfertheiner P (eds): Chronic Pancreatitis. Berlin, Springer, 1990, pp 8–14.
  39. Klöppel G, Maillet B: Chronic pancreatitis: Evolution of the disease. Hepatogastroenterology 1991;38:408–412.
  40. Lankisch PG, Assmus C, Petersen M, Gottesleben F, Dröge M: Acute pancreatitis (AP): How many patients progress to chronic pancreatitis (CP)? (abstr). Gastroenterology 1997;112:A455.
  41. Ahlgren JD: Epidemiology and risk factors in pancreatic cancer. Semin Oncol 1996;23:241–250.

    External Resources

  42. Höpker W-W: Epidemiologie der Pankreaserkrankungen. Verh Dtsch Ges Pathol 1987;71:144–160.

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50